Empagliflozin improves left ventricular diastolic function of db/db mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Empagliflozin improves left ventricular diastolic function of db/db mice

Published:2020-08 Issue:8 Volume:1866 Page:165807
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Moellmann Julia,Klinkhammer Barbara M.,Droste Patrick,Kappel Ben,Haj-Yehia Elias,Maxeiner Sebastian,Artati Anna,Adamski Jerzy,Boor Peter,Schütt Katharina,Lopaschuk Gary D.,Verma Subodh,Marx Nikolaus,Lehrke Michael

Funder

Corona-Stiftung

Medizinische Fakultät, RWTH Aachen University

Bundesministerium für Bildung und Forschung

Boehringer Ingelheim

Deutsche Forschungsgemeinschaft

European Regional Development Fund

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference32 articles.

1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N. Engl. J. Med.,2015

2. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N. Engl. J. Med.,2017

3. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. Reply;Wiviott;N. Engl. J. Med.,2019

4. Empagliflozin increases cardiac energy production in diabetes: novel translational insights into the heart failure benefits of SGLT2 inhibitors;Verma;JACC Basic Transl. Sci.,2018

5. Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus;Marx;Eur. Heart J.,2016

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: Lessons from preclinical studies;Chemico-Biological Interactions;2024-11

2. The effect of sodium-glucose cotransporter type 2 inhibitors on left ventricular diastolic function: current status and prospects;Kardiologiia;2024-07-31

3. Empagliflozin rescues pro-arrhythmic and Ca2+ homeostatic effects of transverse aortic constriction in intact murine hearts;Scientific Reports;2024-07-08

4. Empagliflozin, a sodium‐glucose cotransporter inhibitor enhancing mitochondrial action and cardioprotection in metabolic syndrome;Journal of Cellular Physiology;2024-05-19

5. Secreted frizzled-related protein 2 ameliorates diabetic cardiomyopathy by activating mitophagy;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3